Literature DB >> 30697413

Mantle cell lymphoma-rare differential diagnosis of a tumor in the vermiform appendix.

Stephanie Taha-Mehlitz1, Julia Bockmeyer1, Elza Memeti1, Miriam Nowack2, Jürg Metzger1, Jörn-Markus Gass1.   

Abstract

Although the most common localization of extranodal non-Hodgkin lymphoma is the gastrointestinal system, the infiltration of the vermiform appendix is a very rare condition. We report a case of mantle cell lymphoma affecting the appendix as an incidental finding due to gynecological surgery. A 57-year-old woman presented with increasing pain in the right lower abdomen since months. During gynecological evaluation an inhomogenous mass in the right ovarian place was noticed and misinterpreted as ovarian tumor. Laparoscopic ovarectomy was planned. The intraoperative situs showed surprisingly a massive enlarged appendix and completely normal ovaries. Since the lesion was suspicious for appendiceal cancer, a right hemicolectomy was performed. Histopathology revealed a non-Hodgkin lymphoma with immunohistochemical proof of blastoid B-cells, a mantle cell lymphoma. Polychemotherapy was administered.

Entities:  

Year:  2019        PMID: 30697413      PMCID: PMC6344925          DOI: 10.1093/jscr/rjy367

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


INTRODUCTION

At least one-third of extranodal non-Hodgkin lymphomas appear in the gastrointestinal system, for mantle cell lymphomas (MCL) the amount is ~25% [1, 2]. Whereas the colon is the most common site of gastrointestinal MCL, presenting with polypoid lesions, the appendix is rarely affected, usually by ingrowing of ileocecal region [3]. Different clinical appearance and non-specific symptoms may cause delayed diagnosis. We report a case of a female patient complaining non-specific increasing pain in the right hemiabdomen. The patient was first assessed by the gynecologists. Then laparoscopy revealed a surprising diagnosis.

CASE REPORT

A 57-year-old woman presented with diffuse abdominal pain in the right lower abdominal quadrant since several months. The pain was increasing while sitting, she also suffered from hot flushes and diarrhea. Weight loss, night sweats or fever were not documented. First seen by gynecologists, endovaginal ultrasound showed a solid tumor measuring 10×5×6.5 cm3, with inhomogeneous structure, suspicious of ovarian tumor (Fig. 1). Tumor markers for ovarian carcinoma were inconspicuous, only the CA 125 was slightly elevated (49.2 U/ml, reference <35 U/ml). A diagnostic laparoscopy and ovarectomy were planned.
Figure 1:

Transvaginal ultrasound with inhomogenous mass in the right part of the small pelvis.

Transvaginal ultrasound with inhomogenous mass in the right part of the small pelvis. The diagnostic laparoscopy revealed a strongly thickened and hardened vermiform appendix with a slightly porcelain-like surface and the appendiceal basis was involved (Fig. 2). In addition, massive mesenterial and retroperitoneal lymphadenopathy as well as peritoneal nodules especially in the small pelvis and right lower abdomen were detected (Fig. 3). Since low-grade appendiceal mucinous neoplasm (LAMN) or neuroendocrine tumor were possible differential diagnosis, a midline laparotomy and right-sided hemicolectomy with oncological central lymph node resection was performed. Bowel continuity was restored by a side-to-side anastomosis of the terminal ileum and the transverse colon in hand-sewn technique. Frozen section showed infiltrations of lymphoma.
Figure 2:

Thickened appendix and mesoappendix with porcelain-like suface.

Figure 3:

Peritoneal nodules seen in diagnostic laparoscopy.

Thickened appendix and mesoappendix with porcelain-like suface. Peritoneal nodules seen in diagnostic laparoscopy. The postoperative course and recovery were uneventful. The patient was discharged 11 days after surgery. In the pathological assessment the appendix measured 10 and 4.5 cm in diameter. Histopathology revealed an infiltrating non-Hodgkin lymphoma, blastoid B-cell-type, a mantle cell lymphoma. The immunohistochemical pattern was positive for CD20, CD5, Cyclin D1, bcl-6 (that fits for blastoid type), negative for CD3, CD23 and CD10. MIB-1 was up to 75% (Figs 4 and 5).
Figure 4:

Magnification 10×, hematoxylin and eosin staining shows a monomorphic lymphoid population with a diffuse growth pattern.

Figure 5:

Magnification 40×, the immunohistochemical staining shows strong diffuse nuclear expression of Cyclin D1 (>95% of all mantle cell lymphoma including CD5-negative cases).

Magnification 10×, hematoxylin and eosin staining shows a monomorphic lymphoid population with a diffuse growth pattern. Magnification 40×, the immunohistochemical staining shows strong diffuse nuclear expression of Cyclin D1 (>95% of all mantle cell lymphoma including CD5-negative cases). Staging was completed with positron emission tomography/computed tomography (PET/CT) scan and bone marrow biopsy. Since there were suspicious lymph nodes supra- and infradiaphragmal and no splenomegaly, Ann Arbor Stage IIIA resulted. Polychemotherapy was conducted within a study protocol afterwards.

DISCUSSION

The MCL accounts for 4–9% of all lymphomas. A chromosomal translocation between chromosome 14 and the Cyclin D1 gene on chromosome 11 is pathognomic. The t(11;14)(q13;q32) leads to overexpression of Cyclin D1 and activation of the cell cycle. Immunohistochemical detection of Cyclin D1 or the proof of translocation in fluorescence in situ hybridization is necessary to differentiate from other lymphomas. Extranodal manifestations (e.g. intestinal manifestation) are more frequent than in other lymphomas [4]. The appendix is usually involved by infiltration of ileocecal MCLs per continuity [3]. Appendical lymphomas, with an incidence assumed to be <2% of all gastrointestinal lymphomas, are described to affect typically male patients with median age of 53 years and white race [5-7]. Extranodal lymphomas occur more often in immunocompromised patients, like post-transplant immunosuppressants or those with immunodeficiency syndromes [8]. Clinical findings are very variable. Incidental findings with thickened appendix without any symptoms, as well as a history of abdominal pain, often in the right lower quadrant, fever, diarrhea, nausea and vomiting or gastrointestinal bleeding can be present. Even acute appendicitis due to luminal obstruction is described [7, 9]. One-third of patients with MCL present with systemic B symptoms. Besides unspecific symptoms there are no typical diagnostical and radiological signs. Suspect ultrasound findings of the appendix should be evaluated by CT scan in order to be able to determine a surgical strategy preoperatively. In the CT scan diffuse mural soft-tissue thickening with diameter ~2.5 cm or more and simultaneously abdominal lymphadenopathy may rise the suspicion of appendiceal lymphoma, but there are no pathognomonic patterns [6, 7]. Therefore, the diagnosis is usually confirmed histopathologically. Because of its rarity surgical management of lymphoma affecting the appendix is based on published case reports and case series. There are no clear guidelines for therapeutic treatment. Usually, an appendectomy or right hemicolectomy is performed. Although there seems to be no survival benefit for hemicolectomy in comparison with a single appendectomy. In our case the basis of the appendix was thickened and infiltrated too, therefore, right hemicolectomy was performed. Surgery is followed by adjuvant polychemotherapy and allogenic stem cell transplantation if necessary, depending on stage and histopathological result [5]. In addition to the extent of the surgery, it must also be taken into account that chemotherapy cannot be started immediately after major surgical interventions. It remains unclear if such a delay has an impact on long-term prognosis. After treatment, a close surveillance is recommended. In a cohort of 116 patients the mean overall survival for patients with lymphoma of the vermiform appendix was 185 months and the 5-year survival rate was 67% [5]. Regarding mantle cell lymphoma, the proliferation index Ki67 and its antibody MIB-1 as histopathological parameters have a high prognostic relevance. In addition, clinical aspects as well as the patient’s general condition may help to estimate prognosis in the Mantle Cell Lymphoma International Prognostic Index [10].

CONCLUSION

We described a rare case of mantle cell lymphoma involving the vermiform appendix misinterpreted as ovarian disease. Infiltrating mantle cell lymphoma causing appendiceal tumor is a rare differential diagnosis of right lower abdominal pain and should always be considered preoperatively, especially in cases of conspicuous imaging.
  10 in total

1.  GI manifestations of mantle cell lymphoma.

Authors:  Chor Sang Chim; Wayne H C Hu; Florence Loong; Gaik Cheng Ooi; Raymond Liang
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.

Authors:  Eva Hoster; Andreas Rosenwald; Françoise Berger; Heinz-Wolfram Bernd; Sylvia Hartmann; Christoph Loddenkemper; Thomas F E Barth; Nicole Brousse; Stefano Pileri; Grzegorz Rymkiewicz; Roman Kodet; Stephan Stilgenbauer; Roswitha Forstpointner; Catherine Thieblemont; Michael Hallek; Bertrand Coiffier; Ursula Vehling-Kaiser; Réda Bouabdallah; Lothar Kanz; Michael Pfreundschuh; Christian Schmidt; Vincent Ribrag; Wolfgang Hiddemann; Michael Unterhalt; Johanna C Kluin-Nelemans; Olivier Hermine; Martin H Dreyling; Wolfram Klapper
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

3.  Primary appendiceal lymphoma: clinical characteristics and outcomes of 116 patients.

Authors:  Adil Ayub; Norberto Santana-Rodríguez; Wissam Raad; Faiz Y Bhora
Journal:  J Surg Res       Date:  2016-08-31       Impact factor: 2.192

4.  Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.

Authors:  P J Pickhardt; M J Siegel
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

5.  Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.

Authors:  F d'Amore; H Brincker; K Grønbaek; K Thorling; M Pedersen; M K Jensen; E Andersen; N T Pedersen; L S Mortensen
Journal:  J Clin Oncol       Date:  1994-08       Impact factor: 44.544

Review 6.  Non-Hodgkin's lymphoma of the appendix: clinical and CT findings with pathologic correlation.

Authors:  Perry J Pickhardt; Angela D Levy; Charles A Rohrmann; Susan L Abbondanzo; Amir I Kende
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

Review 7.  Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation.

Authors:  Perry J Pickhardt; Angela D Levy; Charles A Rohrmann; Amir I Kende
Journal:  Radiographics       Date:  2003 May-Jun       Impact factor: 5.333

8.  Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.

Authors:  Jorge E Romaguera; L Jeffrey Medeiros; Frederick B Hagemeister; Luis E Fayad; Maria A Rodriguez; Barbara Pro; Anas Younes; Peter McLaughlin; Andre Goy; Andreas H Sarris; Nan H Dang; Felipe Samaniego; H M Brown; Harish K Gagneja; Fernando Cabanillas
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

Review 9.  Primary lymphoma of the appendix. Case report and review of the literature.

Authors:  M D Pasquale; M Shabahang; P Bitterman; E E Lack; S R Evans
Journal:  Surg Oncol       Date:  1994-08       Impact factor: 3.279

Review 10.  Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.

Authors:  Julie M Vose
Journal:  Am J Hematol       Date:  2017-08       Impact factor: 10.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.